{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:45:08Z","timestamp":1787161508657,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jsat.2021.108377","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T02:58:30Z","timestamp":1616468310000},"page":"108377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Transporting to treatment: Evaluating the effectiveness of a mobile engagement unit"],"prefix":"10.1016","volume":"129","author":[{"given":"Rebecca E.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayoung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Vigderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Candon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen B.","family":"Rothbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108377_bb0005","author":"Abraham"},{"key":"10.1016\/j.jsat.2021.108377_bb0010","author":"Agency for Healthcare Research and Quality"},{"issue":"1","key":"10.1016\/j.jsat.2021.108377_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/ADA-120029870","article-title":"Barriers to enrollment in drug abuse treatment and suggestions for reducing them: Opinions of drug injecting street outreach clients and other system stakeholders","volume":"30","author":"Appel","year":"2004","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"24","key":"10.1016\/j.jsat.2021.108377_bb0020","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1056\/NEJMp1710014","article-title":"Coupling policymaking with evaluation\u2014The case of the opioid crisis","volume":"377","author":"Barnett","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2021.108377_bb0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsat.2011.02.002","article-title":"Factors associated with Medicaid patients\u2019 access to buprenorphine treatment","volume":"41","author":"Baxter","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108377_bb0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0740-5472(03)00188-0","article-title":"Distance traveled to outpatient drug treatment and client retention","volume":"25","author":"Beardsley","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108377_bb0035","author":"CDC Health Alert Network"},{"key":"10.1016\/j.jsat.2021.108377_bb0040","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000679","article-title":"Opioid policy changes during the COVID-19 pandemic\u2014And beyond","author":"Davis","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2021.108377_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2019.01052","article-title":"Lived experience in new models of care for substance use disorder: A systematic review of peer recovery support services and recovery coaching","volume":"10","author":"Eddie","year":"2019","journal-title":"Frontiers in Psychology"},{"key":"10.1016\/j.jsat.2021.108377_bb0050","author":"Enos"},{"issue":"4","key":"10.1016\/j.jsat.2021.108377_bb0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1310\/hpx5204-264","article-title":"21st century cures act","volume":"52","author":"Gabay","year":"2017","journal-title":"Hospital Pharmacy"},{"key":"10.1016\/j.jsat.2021.108377_bb0060","series-title":"Impact evaluation in practice","first-page":"129","article-title":"Difference-in-differences","volume":"Vol. 1\u20130","author":"Gertler","year":"2016"},{"key":"10.1016\/j.jsat.2021.108377_bb0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cct.2016.12.015","article-title":"Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment","volume":"53","author":"Gordon","year":"2017","journal-title":"Contemporary Clinical Trials"},{"issue":"2","key":"10.1016\/j.jsat.2021.108377_bb0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0376-8716(96)01273-2","article-title":"Patient retention in mobile and fixed-site methadone maintenance treatment","volume":"42","author":"Greenfield","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2021.108377_bb0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals","volume":"46","author":"Hall","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"11","key":"10.1016\/j.jsat.2021.108377_bb0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/pds.3851","article-title":"The influence of propoxyphene withdrawal on opioid use in veterans","volume":"24","author":"Hayes","year":"2015","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.jsat.2021.108377_bb0085","series-title":"Drug overdose deaths in the United States, 1999\u20132018","first-page":"8","volume":"356","author":"Hedegaard","year":"2020"},{"issue":"1","key":"10.1016\/j.jsat.2021.108377_bb0090","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1186\/s12913-019-4721-x","article-title":"Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial","volume":"19","author":"Hoffman","year":"2019","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.jsat.2021.108377_bb0095","article-title":"Mobile addiction clinic brings help to those at heart of opioid epidemic","author":"Holmes","year":"2019","journal-title":"CNN"},{"key":"10.1016\/j.jsat.2021.108377_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","article-title":"Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap","volume":"103","author":"Krawczyk","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2021.108377_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.beth.2006.02.009","article-title":"Improving session attendance in mental health and substance abuse settings: A review of controlled studies","volume":"38","author":"Lefforge","year":"2007","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jsat.2021.108377_bb0110","series-title":"Medications for opioid use disorder save lives","first-page":"25310","year":"2019"},{"key":"10.1016\/j.jsat.2021.108377_bb0115","author":"Mobile Health Units"},{"key":"10.1016\/j.jsat.2021.108377_bb0120","series-title":"New evidence on substance use disorders and COVID-19 susceptibility","author":"National Institute on Drug Abuse","year":"2020"},{"issue":"1","key":"10.1016\/j.jsat.2021.108377_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","article-title":"Why don\u2019t out-of-treatment individuals enter methadone treatment programmes?","volume":"21","author":"Peterson","year":"2010","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2021.108377_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/948789","article-title":"Distance traveled and cross-state commuting to opioid treatment programs in the United States","volume":"2011","author":"Rosenblum","year":"2011","journal-title":"Journal of Environmental and Public Health"},{"issue":"1","key":"10.1016\/j.jsat.2021.108377_bb0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1377\/hlthaff.2011.0983","article-title":"Blacks and Hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors","volume":"32","author":"Saloner","year":"2013","journal-title":"Health Affairs (Project Hope)"},{"key":"10.1016\/j.jsat.2021.108377_bb0140","author":"SAMHSA"},{"issue":"6","key":"10.1016\/j.jsat.2021.108377_bb0145","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0306-4603(02)00218-6","article-title":"The influence of distance on utilization of outpatient mental health aftercare following inpatient substance abuse treatment","volume":"28","author":"Schmitt","year":"2003","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2021.108377_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsat.2019.07.001","article-title":"A community outreach intervention to link individuals with opioid use disorders to medication-assisted treatment","volume":"108","author":"Scott","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108377_bb0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2017.12.007","article-title":"Opioid recovery initiation: Pilot test of a peer outreach and modified Recovery Management Checkup intervention for out-of-treatment opioid users","volume":"86","author":"Scott","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108377_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.09.003","article-title":"Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic","volume":"107","author":"Snow","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108377_bb0165","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MLR.0000000000001292","article-title":"Impact of transportation interventions on health care outcomes: A systematic review","volume":"58","author":"Solomon","year":"2020","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2021.108377_bb0170","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2021.108377_bb0175","doi-asserted-by":"crossref","first-page":"108176","DOI":"10.1016\/j.jsat.2020.108176","article-title":"It\u2019s not just the money: The role of treatment ideology in publicly funded substance use disorder treatment","volume":"120","author":"Stewart","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108377_bb0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10742-014-0123-z","article-title":"Using propensity scores in difference-in-differences models to estimate the effects of a policy change","volume":"14","author":"Stuart","year":"2014","journal-title":"Health Services & Outcomes Research Methodology"},{"issue":"5","key":"10.1016\/j.jsat.2021.108377_bb0185","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s10900-013-9681-1","article-title":"Traveling towards disease: Transportation barriers to health care access","volume":"38","author":"Syed","year":"2013","journal-title":"Journal of Community Health"},{"issue":"5","key":"10.1016\/j.jsat.2021.108377_bb0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/02791072.2014.921743","article-title":"Patient perspectives on buprenorphine\/naloxone: A qualitative study of retention during the starting treatment with agonist replacement therapies (START) study","volume":"46","author":"Teruya","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"issue":"22","key":"10.1016\/j.jsat.2021.108377_bb0195","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2021.108377_bb0200","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2021.108377_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jsat.2019.05.005","article-title":"West Virginia\u2019s model of buprenorphine expansion: Preliminary results","volume":"108","author":"Winstanley","year":"2020","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:59Z","timestamp":1760039639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":41,"alternative-id":["S0740547221001033"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108377","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transporting to treatment: Evaluating the effectiveness of a mobile engagement unit","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108377"}}